Vanda's President, CEO ... role of routine and affordable genome sequencing in identifying genetic causes of diseases and facilitating the creation of targeted therapeutics.

Vanda Pharmaceuticals Inc. (Vanda) (Nasdaq: VNDA) today announced participation at the American Academy of Neurology (AAN) ...

Vanda’s President, CEO, and Chairman of the Board, Mihael H. Polymeropoulos, M.D., highlighted the significance of this development as a step towards personalized medicine, moving away from a one-size ...